The field of cancer pathology is continually evolving. Advances in artificial intelligence and digital pathology are expected to enhance diagnostic accuracy and efficiency. Personalized medicine, driven by detailed molecular profiling, is becoming increasingly integral to cancer treatment, promising more tailored and effective therapeutic strategies.
